Medisieve
Magnetic blood-filtration technology for patients needing targeted removal of harmful blood components
Highlights
- New on EvolcAdded 2026-11-08
About Medisieve
MediSieve develops a blood-filtration system that uses nanoengineered magnetic particles and beads to target and remove specific blood components.
Its programs address AAV-neutralising antibodies for gene therapies, IL-6-driven hyperinflammation, and severe malaria through removal of infected red blood cells. The severe-malaria project is grant-funded.
MediSieve Ltd was founded in 2014 and is headquartered in London, United Kingdom. Its team includes a founder and CEO, co-founder, CTO, CFO and scientists.
Product: A magnetic blood-filtration system and related programs for selectively removing targeted blood components.
Jobs at Medisieve
Leadership
- Quentin Pankhurst · Co-founderSource: company website
- George Frodsham · Founder & CEOSource: company website
- Cristina Blanco-Andujar · Chief Technology OfficerSource: company website
- James Keeling · Chief Financial OfficerSource: company website
More biotech & pharma companies
Medley Pharma
Generic medicines and food supplements made and supplied to UK wholesalers, pharmacy chains and the NHSNew on EvolcMedpharm
CDMO developing, testing and manufacturing topical and transepithelial drug products for pharmaceutical and biotechnology companiesNew on EvolcMeiragtx
Develops genetic medicines and gene-regulation technologies for patients with rare and common diseasesNew on EvolcMerel Pharma
Pharmaceutical product development, registration and marketing for global healthcare partnersYoung companyNew on EvolcMestag Therapeutics
Immunology company developing first-in-class antibodies for cancer and inflammatory diseases based on fibroblast biologyNew on EvolcMetrion Biosciences
Preclinical CRO running ion channel, cardiac safety and neuroscience screening for pharma and biotech drug discoveryNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Analytics 4High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Content management
- FramerHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.